Abstract:Chemotherapy is one of the prevailing methods used to treat malignant tumours, but the outcome and prognosis of tumour patients are not optimistic. Cancer cells gradually generate resistance to almost all chemotherapeutic drugs via a variety of distinct mechanisms and pathways. Chemotherapeutic resistance, either intrinsic or acquired, is caused and sustained by reduced drug accumulation and increased drug export, alterations in drug targets and signalling transduction molecules, increased repair of drug-induced DNA damage, and evasion of apoptosis. In order to better understand the mechanisms of chemoresistance, this review highlights our current knowledge of the role of altered drug metabolism and transport and deregulation of apoptosis and autophagy in the development of tumour chemoresistance. Reduced intracellular activation of prodrugs (e.g. thiotepa and tegafur) or enhanced drug inactivation by Phase I and II enzymes contributes to the development of chemoresistance. Both primary and acquired resistance can be caused by alterations in the transport of anticancer drugs which is mediated by a variety of drug transporters such as P-glycoprotein (P-gp), multidrug resistance associated proteins, and breast cancer resistance protein. Presently there is a line of evidence indicating that deregulation of programmed cell death including apoptosis and autophagy is also an important mechanism for tumour resistance to anticancer drugs. Reversal of chemoresistance is likely via pharmacological and biological approaches. Further studies are warranted to grasp the full picture of how each type of cancer cells develop resistance to anticancer drugs and to identify novel strategies to overcome it.

Roles of Drug Metabolism Enzymes in Drug Resistance of Tumor

Impact of drug resistance gene on breast cancer chemotherapy

Drug-metabolizing enzymes: role in drug resistance in cancer

Drug metabolizing enzymes and their inhibitors' role in cancer resistance

Effect of glutamine metabolism on chemoresistance and its mechanism in tumors.

Intervention with drug resistance related to metabolism of cancer cells:advances in research

Molecular mechanisms for tumor resistance to chemotherapy.

Analysis of Tumor Drug Resistance-Associated Proteins by Proteomics Study

Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance

DNA damage and metabolic mechanisms of cancer drug resistance

Research Progress in Toxic Effects of Antitumor Drugs Mediated by Drug Metabolism Enzymes and Isoforms

The tumor microenvironment: a key player in multidrug resistance in cancer

Emerging Nano-Based Strategies Against Drug Resistance in Tumor Chemotherapy

Role of Metabolism in Cancer Cell Radioresistance and Radiosensitization Methods

The role and mechanisms of action of microRNAs in cancer drug resistance

Targeted Drug Nanodelivery and Immunotherapy for Combating Tumor Resistance

Relationship between metabolic reprogramming and drug resistance in breast cancer

Epithelial-Mesenchymal Transition and Drug Resistance: Role, Molecular Mechanisms, and Therapeutic Strategies

Drug resistance and tumor immune microenvironment: An overview of current understandings (Review)

The multi-molecular mechanisms of tumor-targeted drug resistance in precision medicine